AbbVie (ABBV) Net Margin (2012 - 2026)
AbbVie (ABBV) posted Net Margin of 21.27% for Q2 2026, up 15.18 percentage points from 6.08% a year earlier and up 16.63 percentage points from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Net Margin (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at AbbVie was 9.80%, up 3.35 percentage points year-over-year; for FY2025, it came in at 6.91%, down 0.68 percentage points from FY2024.
- Annual Net Margin has declined for four consecutive years, with a five-year change of -3.17 percentage points (FY2020 to FY2025).
- In prior years, AbbVie's Net Margin was 7.59% in FY2024 (-1.36 pp), 8.95% in FY2023 (-11.44 pp), 20.39% in FY2022 (-0.15 pp) and 20.54% in FY2021 (+10.46 pp).
- The Q2 2026 figure stands as the highest quarterly Net Margin since Q3 2022.
- On a year-over-year basis, Net Margin increased in two of the last eight quarters, with an average year-over-year change of -0.14 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was Q4 2021, with a gain of 26.91 percentage points; the weakest was Q1 2023, with a drop of 31.21 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was 4.63% (Q1 2026), 10.93% (Q4 2025) and 1.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.48 Bn | 1,106.07 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 618.81 Bn | 537.34 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 502.02 Bn | 475.14 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 260.90 Bn | 234.58 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 236.67 Bn | 192.07 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.16 Bn | 165.36 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 169.69 Bn | 116.34 Bn | 10.94 Bn | -1.65% |
| 10 | Vertex Pharmaceuticals | 133.10 Bn | 105.11 Bn | 2.84 Bn | 32.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.27% |
| Mar 31, 2026 | 4.63% |
| Dec 31, 2025 | 10.93% |
| Sep 30, 2025 | 1.18% |
| Jun 30, 2025 | 6.08% |
| Mar 31, 2025 | 9.64% |
| Dec 31, 2024 | -0.15% |
| Sep 30, 2024 | 10.80% |
| Jun 30, 2024 | 9.47% |
| Mar 31, 2024 | 11.12% |
| Dec 31, 2023 | 5.75% |
| Sep 30, 2023 | 12.77% |
| Jun 30, 2023 | 14.60% |
| Mar 31, 2023 | 1.96% |
| Dec 31, 2022 | 16.35% |
| Sep 30, 2022 | 26.66% |
| Jun 30, 2022 | 6.34% |
| Mar 31, 2022 | 33.17% |
| Dec 31, 2021 | 27.17% |
| Sep 30, 2021 | 22.17% |
API Access
AbbVie Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();